Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45,504,462
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
2,830,846
-
Shares change
-
-220,181
-
Total reported value, excl. options
-
$3,283,550
-
Value change
-
-$215,433
-
Put/Call ratio
-
11%
-
Number of buys
-
1
-
Number of sells
-
6
-
Price
-
$1.16
Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q1 2023
As of 31 Mar 2023 Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,830,846 shares of stock of the company.
Largest 8 holders included Knoll Capital Management, LLC, RA CAPITAL MANAGEMENT, L.P., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, PNC Financial Services Group, Inc., UBS Group AG, JPMORGAN CHASE & CO, and MORGAN STANLEY.
This table shows 8 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.